Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
3.260
0.00 (0.00%)
May 12, 2025, 4:00 PM - Market closed
Senti Biosciences Employees
Senti Biosciences had 34 employees as of December 31, 2024. The number of employees decreased by 14 or -29.17% compared to the previous year.
Employees
34
Change (1Y)
-14
Growth (1Y)
-29.17%
Revenue / Employee
n/a
Profits / Employee
-$1,685,676
Market Cap
84.77M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34 | -14 | -29.17% |
Dec 31, 2023 | 48 | -74 | -60.66% |
Dec 31, 2022 | 122 | 33 | 37.08% |
Dec 31, 2021 | 89 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SNTI News
- 4 days ago - Senti Bio Releases Mechanism of Action Video for First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 - GlobeNewsWire
- 6 days ago - Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development - GlobeNewsWire
- 11 days ago - Senti Bio Releases Virtual Investor “What This Means” Segment - GlobeNewsWire
- 12 days ago - Senti Bio to Present at the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 14 days ago - Senti Bio's SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML - GlobeNewsWire
- 18 days ago - Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 on Monday, April 28th at 8:30 AM ET - GlobeNewsWire
- 21 days ago - Senti Bio Participates in a Virtual Investor KOL Connect Segment - GlobeNewsWire
- 26 days ago - Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment - GlobeNewsWire